Johnson & Johnson (JNJ)
Johnson & Johnson Market Cap : 575.08B for April 6, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Amgen, Inc. | 181.80B |
| Gilead Sciences, Inc. | 174.48B |
| Regeneron Pharmaceuticals, Inc. | 80.80B |
| Protagonist Therapeutics, Inc. | 6.514B |
| Moderna, Inc. | 19.16B |
Market Cap Related Metrics
| PE Ratio | 21.62 |
| PS Ratio | 6.154 |
| PEG Ratio | 0.2388 |
| Price to Book Value | 7.052 |
| Price to Free Cash Flow | 29.43 |
| Price | 240.97 |
| Earnings Yield | 4.63% |
| PEGY Ratio | 0.2388 |
| Operating PE Ratio | 22.62 |
| Normalized PE Ratio | 25.10 |